Ayushi Chauhan

Glofitamab crosses the blood brain barrier and exhibits activity against primary and secondary CNS lymphoma ⁦@BloodAdvances⁩ American Society of Hematology ashpublications.org/bloodadvances/…

👏👏 Kudos to timely and highly informative #ClinicalPractice Recommendations for #Transplantation in Classical Hodgkin Lymphoma in @ASTCT --> led by @MDAndersonNews Dr Sairah Ahmed & @MSKCancerCenter Dr Miguel-Angel Perales: sciencedirect.com/science/articl…

Did you know you can calculate the exact sample size you need before you even start your study? A sample size calculation — also called a power analysis — helps you determine the optimal number of observations for your statistical analysis. It ensures your study is large enough to detect meaningful effects, but not so large that you waste resources. Key advantages of performing a power analysis: ✔️ Avoid underpowered studies that might miss real effects ✔️ Save time and costs by avoiding unnecessarily large samples ✔️ Tailor your sample size to the effect size you care about detecting ✔️ Choose your desired confidence level and statistical power for robust results ✔️ Works for a wide range of statistical tests, from t‑tests to ANOVA and regression ✔️ Supported by many free R packages, such as pwr The image shows on the left side how the required sample size changes depending on the expected effect size — smaller effects require much larger samples. On the right side, you see an example of a calculated sample size for comparing two groups using a t-test, showing exactly how many participants are needed per group for the desired confidence level and statistical power. Sign up for my newsletter to get more practical tips on statistics, data science, R, and Python. Check out this link for more details: eepurl.com/gH6myT #pythonprogramming #programmer #DataAnalytics #RStats #Python #datastructure #DataAnalytics

Have followed #HealthcareUnfiltered podcast for sometime now especially for focus on outcomes, trial designs, and equitable access. What serendipity to meet @chadinabhan in person at 🩸#ASH25! Looking forward to staying in touch! @WomenInLymphoma @MDAndersonNews #endcancer

We had a great turnout today at our @MedscapeOnc symposium on R/R #PCNSL! #ASH25 ❤️ SO much to look forward to in this space! Thx to Dr D’Angelo & my friend @Chauhan_AF for making it a great discussion! #btsm

Rapid dose escalation glofi/epco #ASH25 - 30 pts w rapid escalation - median time to 1st full dose: 6 d epco, 14 d glofi - 16 CRS (2 G3), 7 ICANS (2 G3-4) - More CRS/ICANS than std escalation pts in CUBIC consortium registry. Looking forward to future subgroup analysis. #lymsm